Jen Li
LightNews LightNews
banner
drjenkidney.bsky.social
Jen Li
@drjenkidney.bsky.social
400 followers 200 following 88 posts
Transplant Nephrologist | Clinician Researcher @westmeadinst.bsky.social | #whatstheclincialrelevance
Posts Replies Media Videos
Reposted by Jen Li
jef.works
What is RNA velocity in situ? ChatGPT kept getting it wrong...

So I made this video explaining how RNA velocity in situ infers gene expression dynamics by distinguishing nuclear vs. cytoplasmic expression in spatial transcriptomics data: youtu.be/z9Oxf1hvum0

#AcademicSky
RNA velocity in situ infers gene expression dynamics using spatial transcriptomics data
YouTube video by Prof. Jean Fan
youtu.be
October 13, 2025 at 7:09 PM
Reposted by Jen Li
edgarvlermamd.bsky.social
Actionable genes in CKD ca. 2024 from @kdigo.org
#RKDSummit #Nephpearls #NephSky

👉 kdigo.org/guidelines/c...
October 11, 2025 at 3:25 PM
Reposted by Jen Li
kidneyint.bsky.social
Changing paradigms of studies in kidney diseases

doi.org/10.1016/j.kint.2025.09.016

#OpenAccess #NephSky #MedSky #kidneydisease #CKD
@sydney.edu.au @uofglasgow.bsky.social @fbmh-uom.bsky.social @ucl.ac.uk @livuni-ilcams.bsky.social @flindersuniversity.bsky.social @theisn.org
October 8, 2025 at 2:50 PM
Reposted by Jen Li
lgmartelotto.bsky.social
iSCALE

www.nature.com/articles/s41...
Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE - Nature Methods
iSCALE leverages histology and spatial transcriptomics to infer gene expression at super resolution in large tissues.
www.nature.com
October 3, 2025 at 11:54 PM
Reposted by Jen Li
labwaggoner.bsky.social
Review: The relationship between genetic mutations and formation of specific amyloid fibril structures drives inheritance patterns of amyloid diseases
www.science.org/doi/10.1126/...
October 1, 2025 at 7:23 PM
Reposted by Jen Li
acyn.bsky.social
OBAMA: It's fair to say that 80% of the world's problems involve old men hanging on who are afraid of death and insignificance, and they won't let go. They build pyramids, and they put their names on everything. They get very anxious about it.
September 25, 2025 at 6:02 PM
Reposted by Jen Li
transplantation.bsky.social
New in Transplantation! Patient Selection for Xenotransplant Human Clinical Trials: A Data-driven Approach. #TXPforAll #Transplantation tinyurl.com/4fwsv44c
September 24, 2025 at 12:28 PM
Reposted by Jen Li
wholesomememe.bsky.social
September 23, 2025 at 2:30 AM
Reposted by Jen Li
nkf-professionals.bsky.social
👏 Congratulations to Katalin Susztak, MD, PhD, recipient of the 2026 David M. Hume Memorial Award!

Learn more ➡️ bit.ly/47Taye5

We look forward to celebrating our award winners at SCM26 #NKFClinicals. Stay tuned for registration opening October 2025.

@ksusztak.bsky.social
September 21, 2025 at 5:03 PM
Reposted by Jen Li
brianrifkin.bsky.social
🚨Check out the latest KI Reports community blog on the personalization of immunosuppression from @drpriyajohn.bsky.social
#NephSky

www.kireportscommunity.org/post/persona...
Personalising Immunosuppression:Is Tacrolimus C/D Ratio the New frontier in predicting allograft outcomes
Written by  Priyadarshini John DMReviewed by Sophia Ambruso, DOKidney transplantation remains the most effective form of treatment for end-stage renal disease, with a substantial improvement in patien...
www.kireportscommunity.org
September 20, 2025 at 1:33 AM
Reposted by Jen Li
hjanders.bsky.social
Now open access in @NDTsocial

Anti-GBM disease - Treatment Standard

🧐 Anti-GBM and ANCA positive pts have a higher relapse risk and require maintenance immunosuppressive treatment

▶️ academic.oup.com/ndt/article/...
September 18, 2025 at 8:15 PM
Reposted by Jen Li
kdigo.org
KDIGO is pleased to announce the publication of the 2025 IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV) Guideline, along with its Executive Summary in @kidneyint.bsky.social.

Download: kdigo.co/KDIGO-IgAN-I...

Read in KI: kdigo.co/KDIGO-IgAN-I...

Exec Summary: kdigo.co/IgAN-IgAV-Gu...
September 18, 2025 at 10:34 AM
Reposted by Jen Li
ttsorg.bsky.social
Don't miss the latest Behind the Paper with David K.C. Cooper!
Watch or listen to an in-depth interview on the recent @transplantation.bsky.social paper 👉 The Relative Roles of Inflammation in Kidney Allotransplantation and Xenotransplantation

🔗 tinyurl.com/mr47jdzk
September 11, 2025 at 4:04 PM
Reposted by Jen Li
transplantation.bsky.social
Extracorporeal photopheresis shows promise in reducing donor-specific antibodies and improving long-term transplant survival. #TXPforAll #OpenAccess #Transplantation tinyurl.com/md9b2h3w
September 16, 2025 at 12:00 PM
Reposted by Jen Li
labwaggoner.bsky.social
Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infections @moltherapy.bsky.social
@idibaps.bsky.social
www.cell.com/molecular-th...
September 16, 2025 at 4:41 PM
Reposted by Jen Li
alessandraorsillo.bsky.social
Excited to share our publication in Kidney International Reports with thanks to @georginairish.bsky.social @philclayton.bsky.social

@tregaustralia.bsky.social

doi.org/10.1016/j.ek...
September 15, 2025 at 8:58 PM
drjenkidney.bsky.social
🤩🎉 well deserved @georginairish.bsky.social - onwards to more great work and contributions to the transplant field
tregaustralia.bsky.social Transplant Epidemiology Group Australia @tregaustralia.bsky.social · Sep 16
Huge congratulations to @tregaustralia.bsky.social's @georginairish.bsky.social who has just been awarded her PhD titled "Decision making in Kidney Transplantation" /1
September 16, 2025 at 11:06 AM
drjenkidney.bsky.social
Important to consider recipient DM status if we accept diabetic kidneys for transplantation
September 16, 2025 at 2:17 AM
drjenkidney.bsky.social
I recall studying the complement system as part of med school, physician training and PhD, yet there's still so much to learn to understand how this can impact health and clinical care. #understandfundamentals #internationalcomplementworkshop #icw2025
September 14, 2025 at 12:24 AM
drjenkidney.bsky.social
We need to do better, esp for PD patients
September 13, 2025 at 8:40 PM
drjenkidney.bsky.social
Making the most of September's opportunities 🙏
- Biomarkers in KTx #ANZSN2025
- MGRS/malignancy in glom disease #ANZGlomerularDiseaseWorkshop
- virtually tune in for the Mayo Onconeph Symposium

Ready to absorb complement knowledge with Int Complement Congress tmr 😬 before back to the daily grind
September 13, 2025 at 11:40 AM
Reposted by Jen Li
thesampsonlab.bsky.social
Nephrotic syndrome doesn’t just cause swelling; it can lead to infections, blood clots, kidney damage, and many other complications. 💧🩸🦠

📌 Learn more about our research and how you can support families affected by kidney disease at the link in our bio. #nephrology #genomics
September 12, 2025 at 8:02 PM
drjenkidney.bsky.social
Sign up for the upcoming webinar (next week!) to learn about the impact of SOT in HCT recipients and vice versa @ttsorg.bsky.social @transplantation.bsky.social
#TTSEducation

tts.org/join-tts/116...
September 9, 2025 at 6:57 PM
drjenkidney.bsky.social
A timely SR and meta analysis highlighting the likely benefits of SGLT2i and GLP1ra in transplantation. @ttsorg.bsky.social @transplantation.bsky.social

LIsten to Leo Riella give an excellent summary - TTS pulse podcast on Spotify with @drmaceylevan.bsky.social

open.spotify.com/show/0srDXx3...
September 9, 2025 at 6:47 PM
drjenkidney.bsky.social
Check out the latest from @transplantation.bsky.social @ttsorg.bsky.social @drmaceylevan.bsky.social

tts.org/index.php?op...
September 9, 2025 at 6:33 PM